ATXS Live signaler | Maksimer profitt med Getagraph.com

KJøP 123081 min ago

@ $14.28

Utstedt: 14 feb 2024 @ 18:06

Avkastning: -28.78%

Forrige signal: feb 13 - 20:46

Forrige signal: Selg

Avkastning: -0.35 %

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 22:00):

Stats
Dagens volum	654 090
Gjennomsnittsvolum	1.02M
Markedsverdi	558.47M
EPS	$0 ( 2024-05-09 )
Neste inntjeningsdato	( $-0.360 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.20
ATR14	$0.0180 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Agarwal Sunil	Buy	28 200	Stock Option (Right to Buy)
2024-04-05	Agarwal Sunil	Buy	0
2024-04-01	Morabito Christopher	Sell	10 000	Stock Option (Right to Buy)
2024-04-01	Morabito Christopher	Buy	10 000	Common Stock
2024-04-01	Morabito Christopher	Sell	10 000	Common Stock

INSIDER POWER
96.96
Last 97 transactions
Buy: 15 860 733 \| Sell: 474 752

Volum Korrelasjon

Lang: -0.09 (neutral)

Kort: 0.35 (neutral)

Signal:(45.11) Neutral

Astria Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Astria Therapeutics, Inc. Korrelasjon - Valuta/Råvare

0.49
( neutral )

0.52
( weak )

0.00
( neutral )

0.55
( weak )

-0.79
( moderate negative )

-0.48
( neutral )

Astria Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.42

FY	2023
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-2.42

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-3.43

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-49.16

Financial Reports:

No articles found.

Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.